Corbett Th
Impact in
- Oncology top 10%
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology
- Drug Transport and Resistance Mechanisms
- Colorectal Cancer Treatments and Studies
Papers in
- Oncology 5
- Cancer Cells and Metastasis 3
-
- Cancer therapeutics and mechanisms 3
- Viral Infectious Diseases and Gene Expression in Insects 1
- Co-authors
- Schabel Fm (8 shared papers)Griswold Dp (8 shared papers)Trader Mw (4 shared papers)Laster Wr (4 shared papers)Skipper He (2 shared papers)Linda Simpson‐Herren (1 shared paper)
- Journals
- PubMed (9 papers)
In The Last Decade
Corbett Th
9 papers receiving 606 citations
Corbett Th's Hit Papers
Peers
Comparison fields: 5 of 76
- Oncology 369
- Toxicology 17
- Otorhinolaryngology 20
- Reproductive Medicine 36
- Pulmonary and Respiratory Medicine 127
Countries citing papers authored by Corbett Th
This map shows the geographic impact of Corbett Th's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Corbett Th with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Corbett Th more than expected).
Fields of papers citing papers by Corbett Th
This network shows the impact of papers produced by Corbett Th. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Corbett Th. The network helps show where Corbett Th may publish in the future.
Co-authors
The 6 scholars most cited alongside Corbett Th, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice. Hit paper breakdown → | 1980 | 394 |
| 2 | Establishment of cross-resistance profiles for new agents. | 1983 | 126 |
| 3 | Biology and therapeutic response of a mouse mammary adenocarcinoma (16/C) and its potential as a model for surgical adjuvant chemotherapy. | 1978 | 91 |
| 4 | Concepts for controlling drug-resistant tumor cells. | 1980 | 46 |
| 5 | Response of transplantable tumors of mice to anthracenedione derivatives alone and in combination with clinically useful agents. | 1982 | 41 |
| 6 | Design and evaluation of combination chemotherapy trials in experimental animal tumor systems. | 1979 | 24 |
| 7 | Response of five established solid transplantable mouse tumors and one mouse leukemia to hyperbaric hydrogen. | 1978 | 13 |
| 8 | Clonogenicity and growth of experimental tumors in relation to developing resistance and therapeutic failure. | 1981 | 11 |
| 9 | Studies of the growth, population kinetics, and host lethality of CD8F mammary adenocarcinoma. | 1978 | 1 |
About Corbett Th
Corbett Th is a scholar working on Oncology, Molecular Biology, Organic Chemistry, Surgery and Pulmonary and Respiratory Medicine, having authored 9 papers that have together received 747 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (3 papers), Cancer therapeutics and mechanisms (3 papers), Advanced Breast Cancer Therapies (1 paper), Estrogen and related hormone effects (1 paper), Viral Infectious Diseases and Gene Expression in Insects (1 paper), Cancer Genomics and Diagnostics (1 paper), Hydrogen's biological and therapeutic effects (1 paper) and Click Chemistry and Applications (1 paper). The work is most often cited by research in Oncology (369 citations), Toxicology (17 citations), Otorhinolaryngology (20 citations), Reproductive Medicine (36 citations) and Pulmonary and Respiratory Medicine (127 citations). Frequent co-authors include Schabel Fm, Griswold Dp, Trader Mw, Laster Wr, Skipper He and Linda Simpson‐Herren. Their work appears in journals such as PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.